[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338941-105":59,"doc-detail-338941-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","sarcopenic-obesity-in-cancer-review","Sarcopenic obesity in cancer - review","","Sarcopenic obesity is a clinical condition defined by the coexistence of sarcopenia (loss of muscle mass and function) and obesity (increased fat mass), mainly affecting older adults but increasingly recognized across age groups in cancer. Its presence is linked with worse treatment outcomes, longer hospital stays, physical disability, and shorter survival in several cancers. Oxidative stress, lipotoxicity, systemic inflammation, and changes in skeletal muscle anti-inflammatory myokines contribute to shared mechanisms with carcinogenesis.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sarcopenic-obesity-in-cancer-review/338941/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sarcopenic-obesity-in-cancer-review/338941.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is sarcopenic obesity and why is it important in cancer?","Question",{"text":113,"@type":114},"Sarcopenic obesity combines sarcopenia and obesity. In cancer patients, it is associated with poorer outcomes, longer hospitalization, physical disability, and reduced survival.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What shared mechanisms link sarcopenic obesity and cancer?",{"text":118,"@type":114},"Inflammation, oxidative stress, and insulin resistance are highlighted as key shared pathogenetic mechanisms relevant to both conditions.",{"name":120,"@type":111,"acceptedAnswer":121},"How is sarcopenic obesity identified and diagnosed?",{"text":122,"@type":114},"Identification uses definitions and diagnostic criteria that combine increased BMI or waist circumference with ethnicity-specific cut-offs plus surrogate measures of sarcopenia, and requires altered body composition for a definitive diagnosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338941,1790174756,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":46,"preview_page_count":19,"preview_urls":145},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","[Radiology and Oncology | Ljubljana | Slovenia | www.radioloncol.com](Radiology and Oncology | Ljubljana | Slovenia | www.radioloncol.com)    \n1  \nreview  \nSarcopenic obesity in cancer  \nMihaela Jurdana1 , Maja Cemazar1,2  \n1 Faculty of Health Sciences, University of Primorska, Izola, Slovenia  \n2 Institute of Oncology Ljubljana, Ljubljana, Slovenia Radiol Oncol 2024; 58(1): 1-8.  \nReceived 2 November 2023 Accepted 4 December 2023  \nCorrespondence to: Mihaela Jurdana, Ph.D., Faculty of Health Sciences, University of Primorska, Polje 42, Izola, Slovenia.  \n[E-mail: mihaela.jurdana@fvz.upr.si](E-mail: mihaela.jurdana@fvz.upr.si)  \nDisclosure: No potential conflicts of interest were disclosed.  \nThis is an open access article distributed under the terms of the CC-BY license ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)).  \nBackground. Sarcopenic obesity is a relatively new term. It is a clinical condition characterized by sarcopenia (loss of muscle mass and function) and obesity (increase in fat mass) that mainly affects older adults. As the incidence of sarcopenia and obesity increases worldwide, sarcopenic obesity is becoming a greater problem also in cancer patients. In fact, sarcopenic obesity is associated with poorer treatment outcomes, longer hospital stays, physical disability, and shorter survival in several cancers. Oxidative stress, lipotoxicity, and systemic inflammation, as well as altered expression of skeletal muscle anti-inflammatory myokines in sarcopenic obesity, are also associated with carcinogenesis. Conclusions. Reported prevalence of sarcopenic obesity in cancer varies because of heterogeneity in definitionsand variability in diagnostic criteria used to estimate the prevalence of sarcopenia and obesity. Therefore, the aim of this review is to describe the definitions, prevalence, and diagnostic criteria as well as the mechanisms that cancer has in common with sarcopenic obesity.  \nKey words: sarcopenia; obesity; cancer; inflammation  \nIntroduction  \nSarcopenic obesity is a clinical condition characterised by the coexistence of obesity, excess fat mass (FM) and sarcopenia (decrease in skeletal muscle mass and function) .1,2 Baumgartner was the first to propose the term sarcopenic obesity, which is considered a unique clinical condition distinct from obesity and sarcopenia alone.1 The prevalence of sarcopenic obesity is expected to become a public health problem as the prevalence of sarcopenic obesity in adults is rapidly increasing worldwide. The clinical consequences of sarcopenic obesity are considerably more severe than those of sarcopenia or obesity alone. In comparison to both, it can lead to physical disability, morbidity, and even mortality.3 In addition, cancer is another serious global health problem with increasing incidence and mortality worldwide.4 Interestingly, sarcopenic obesity is more common in older adult cancer patients and patients with other chronic diseases,  \nbut its prevalence is also increased in younger patients with obesity and chronic diseases such as cancer and is associated with worse treatment outcomes.5 Sarcopenic obesity and cancer, as well as other chronic diseases, share some key pathogenetic mechanism such as inflammation, oxidative stress, and insulin resistance, which are considered key factors.6-8 Among these, insulin resistance is considered a central condition in both, cancer and sarcopenic obesity.8  \nSeveral factors in sarcopenic obesity may lead to progressive loss of muscle mass and altered fat metabolism, which influence each other in a reciprocal pattern. Sarcopenia is known to be a common problem in cancer patients, especially if they are suffering cachexia and is associated with physical disability, surgical complications, increased risk of severe toxicity during cancer treatment, prolonged hospitalisation, and shortened survival.6 Sarcopenia can occur at any stage of cancer and in any body mass index (BMI) categ","cbCaiqFFBVevVDqz","https://ap.wps.com/l/cbCaiqFFBVevVDqz","pdf",491942,"English","# Introduction\n# Identification of sarcopenic obesity and diagnostic criteria","[{\"question\":\"What is sarcopenic obesity and why is it important in cancer?\",\"answer\":\"Sarcopenic obesity combines sarcopenia and obesity. In cancer patients, it is associated with poorer outcomes, longer hospitalization, physical disability, and reduced survival.\"},{\"question\":\"What shared mechanisms link sarcopenic obesity and cancer?\",\"answer\":\"Inflammation, oxidative stress, and insulin resistance are highlighted as key shared pathogenetic mechanisms relevant to both conditions.\"},{\"question\":\"How is sarcopenic obesity identified and diagnosed?\",\"answer\":\"Identification uses definitions and diagnostic criteria that combine increased BMI or waist circumference with ethnicity-specific cut-offs plus surrogate measures of sarcopenia, and requires altered body composition for a definitive diagnosis.\"}]","Sarcopenic obesity in cancer - review | PDF",1790026667,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ccc2d9c770bff010fde6b108b6c2ad42.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a765aa8c385418c0ae471387d2345b8d.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8046656f55c11e825ff2dd30008e0966.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6228cc52a8d5c10a195ffde886041c5b.webp",980,1306]